Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 20040913)


Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB).

Gray SJ, Blake BL, Criswell HE, Nicolson SC, Samulski RJ, McCown TJ, Li W.

Mol Ther. 2010 Mar;18(3):570-8. doi: 10.1038/mt.2009.292. Epub 2009 Dec 29. Erratum in: Mol Ther. 2010 May;18(5):1054. Li, Wuping [added].


Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity.

McCown TJ.

Neurotherapeutics. 2009 Apr;6(2):307-11. doi: 10.1016/j.nurt.2009.01.004. Review.


Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.

Foti S, Haberman RP, Samulski RJ, McCown TJ.

Gene Ther. 2007 Nov;14(21):1534-6. Epub 2007 Aug 23.


The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5.

Weinberg MS, Blake BL, Samulski RJ, McCown TJ.

Gene Ther. 2011 Oct;18(10):961-8. doi: 10.1038/gt.2011.49. Epub 2011 Apr 14.


Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity.

Haberman R, Criswell H, Snowdy S, Ming Z, Breese G, Samulski R, McCown T.

Mol Ther. 2002 Oct;6(4):495-500.


Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.

Yang L, Li J, Xiao X.

Methods Mol Biol. 2011;709:127-39. doi: 10.1007/978-1-61737-982-6_8.


Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain.

Markakis EA, Vives KP, Bober J, Leichtle S, Leranth C, Beecham J, Elsworth JD, Roth RH, Samulski RJ, Redmond DE Jr.

Mol Ther. 2010 Mar;18(3):588-93. doi: 10.1038/mt.2009.286. Epub 2009 Dec 15.


Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.

Dodiya HB, Bjorklund T, Stansell J 3rd, Mandel RJ, Kirik D, Kordower JH.

Mol Ther. 2010 Mar;18(3):579-87. doi: 10.1038/mt.2009.216. Epub 2009 Sep 22.


Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice.

Gholizadeh S, Tharmalingam S, Macaldaz ME, Hampson DR.

Hum Gene Ther Methods. 2013 Aug;24(4):205-13. doi: 10.1089/hgtb.2013.076. Epub 2013 Aug 3.


The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy.

McCown TJ.

Drug News Perspect. 2010 Jun;23(5):281-6. doi: 10.1358/dnp.2010.23.5.1468393. Review.


Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling.

Kienle E, Senís E, Börner K, Niopek D, Wiedtke E, Grosse S, Grimm D.

J Vis Exp. 2012 Apr 2;(62). pii: 3819. doi: 10.3791/3819.


Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development.

Lin EJ, Richichi C, Young D, Baer K, Vezzani A, During MJ.

Eur J Neurosci. 2003 Oct;18(7):2087-92.


Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion.

Haberman RP, Samulski RJ, McCown TJ.

Nat Med. 2003 Aug;9(8):1076-80. Epub 2003 Jul 13.


AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity.

Guggenhuber S, Monory K, Lutz B, Klugmann M.

PLoS One. 2010 Dec 21;5(12):e15707. doi: 10.1371/journal.pone.0015707.


Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.

Lochrie MA, Tatsuno GP, Arbetman AE, Jones K, Pater C, Smith PH, McDonnell JW, Zhou SZ, Kachi S, Kachi M, Campochiaro PA, Pierce GF, Colosi P.

Virology. 2006 Sep 15;353(1):68-82. Epub 2006 Jun 30.


AAV-mediated liver-directed gene therapy.

Sands MS.

Methods Mol Biol. 2011;807:141-57. doi: 10.1007/978-1-61779-370-7_6.


Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.

Qi YF, Li QH, Shenoy V, Zingler M, Jun JY, Verma A, Katovich MJ, Raizada MK.

Clin Exp Pharmacol Physiol. 2013 Jan;40(1):53-5. doi: 10.1111/1440-1681.12037.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk